# KANUMA

NDC: 25682-007
Generic name: Sebelipase alfa
Labeler / Manufacturer: Alexion Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION, CONCENTRATE
Routes: INTRAVENOUS
Marketing started: 20151208

FDA application: BLA125561

## Active ingredients

- SEBELIPASE ALFA: 2 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"25682-007"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=25682-007
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=83a77b9d-42f0-4645-8420-786285da7326